[Huajian Medical's Market Value Soars by HK$14 Billion in Two Months with RWA Digital Asset Deployment] According to 21CBR, Huajian Medical announced the completion of the Nanjing ETHK Building, positioned as the world's first research and development base dedicated to Real-World Asset (RWA) digitization technology. Since July, Huajian Medical has acquired Guofu Quantum and established an innovative drug intellectual property tokenization fund, with its market value rising from HK$3 billion to HK$17 billion. The company has been renamed 'Huajian Digital Industry Group' and has partnered with Renhe Pharmaceutical to jointly build an OTC drug RWA exchange in the U.S., promoting the digitization and on-chain circulation of medical assets.